FADO: Fascial Versus Standard Neck Dissection in Patients With N1b Papillary Thyroid Carcinoma

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Other)
Overall Status
Completed
CT.gov ID
NCT05804682
Collaborator
(none)
195
1
61
3.2

Study Details

Study Description

Brief Summary

Optimal surgical technique for neck dissection (LND) in thyroid carcinoma remains a subject of debate. Fascial ND (FND) implies the removal of the superficial and middle layers of the deep cervical fascia en bloc with lymph-nodes containing fibro-fatty tissue (levels IIa-Vb and VI-VII for cN1b patients). This retrospective cohort study was designed to compare FND with standard, non-fascial, selective ND (SND).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Fascial Neck Dissection
  • Procedure: Standard Neck Dissection

Detailed Description

In thyroid cancer patients, lymph node dissection includes a comprehensive removal of all the target nodal basins: anterior cervical compartment (level VI) and the superior mediastinal nodes that can be reached via cervical incision (level VII) in CND, and levels IIa-Vb in LND. Clearance of those levels without including the enveloping fasciae in the specimen is referred to hereafter as Standard Neck Dissection (SND), as it is the most common technique applied for thyroid tumors. In Fascial Neck Dissection, the comprehensive clearance of the target basins is achieved by following the planes of coalescence of the cervical fascial layers. Those are avascular and enable the removal of the target nodes en bloc with their investing fascial layers.

The aim of this retrospective study was to compare the outcomes between fascial and standard approach in N1b PTC patients that underwent surgery for N1b papillary thyroid cancer. The primary objective was to achieve a significantly higher nodal yield by applying the fascial neck dissection technique and reduce rates of early loco-regional recurrence. Secondary objectives were the evaluation of short and long-term post-operative complications and the cosmetic result.

Study Design

Study Type:
Observational
Actual Enrollment :
195 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Fascial Versus Standard Neck Dissection in Patients With N1b Papillary Thyroid Carcinoma: a 4-year Analysis of Outcomes.
Actual Study Start Date :
Jan 1, 2018
Actual Primary Completion Date :
Dec 31, 2021
Actual Study Completion Date :
Jan 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients that underwent fascial dissection for N1b papillary thyroid cancer

Procedure: Fascial Neck Dissection
Central and lateral neck dissection with the fascial technique

Patients that underwent ftandard dissection for N1b papillary thyroid cancer

Procedure: Standard Neck Dissection
Central and lateral neck dissection with the standard technique

Outcome Measures

Primary Outcome Measures

  1. Early loco-regional recurrence [Interventions 2018-2021, Final follow up January 2023]

    Locoregional recurrence within 1 year from operation

  2. Harvested lymph nodes [Interventions 2018-2021, Final follow up January 2023]

    Total and positive lymph node yields for central and lateral compartments

Secondary Outcome Measures

  1. Early and late complications [Interventions 2018-2021, Final follow up January 2023]

  2. Voice and swallowing score comparisons [Interventions 2018-2021, Final follow up January 2023]

  3. Cosmetic outcome [Interventions 2018-2021, Final follow up January 2023]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Patients who met all the following criteria were eligible for inclusion in this retrospective evaluation:

  • Male or female patients, living or deceased, aged 18 years or older at the time of operation

  • Unilateral (left/right) or bilateral lateral neck dissection along with central neck dissection

  • Patients with papillary cancer, pN1b. This excludes patients with other types of thyroid cancer (e.g., medullary, follicular, and anaplastic);

  • Patients that underwent central and/or lateral neck dissection as a primary intervention. This excludes patients with any previous operation for thyroid disease involving any type of lymph node dissection.

Exclusion criteria: patient's age < 18 years, patients that underwent previous neck dissection of any type and patients who refused or were unable to provide adequate follow up data.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy 00168

Sponsors and Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ClinicalTrials.gov Identifier:
NCT05804682
Other Study ID Numbers:
  • 4818
First Posted:
Apr 7, 2023
Last Update Posted:
Apr 7, 2023
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 7, 2023